Logo of BIofidus AG

Serum and Plasma Assays

To predict the in vivo properties of a new biological entity (NEB) as precise as possible, it is inevitable to evaluate its stability and biological activity in a simulated natural environment.   

At Biofidus AG we have access to fresh human whole blood, plasma and serum for performing bioactivity and stability assays. We offer a detailed characterization of degradation and efficacy profiles for your active pharmaceutical ingredient (API).Our experts in this field will guide you through the variety of available assay types and help you find the optimal analytical setup for your project.

In accordance with your needs, we adapt and, if required, qualify (according to ICH guidelines) our platform methods tailored to your API, its individual formulation matrix and your distinct analytical question. 

Get in contact with us to quickly find the optimal setup for your analytical challenge and to speak directly from expert to expert.

Our capabilities

Standalone and integral bioanalytical services

draft of chemical sctructure of a fictive carbon hydrate backbone
PRIMARY STRUCTURE CHARACTERIZATION
draft of 8 rectangularly ordered capsules with one capsule shown upside down
IMPURITY ANALYSIS
draft of chemical sctructure of a fictive carbon hydrate backbone with two phenyl groups
AMINO ACID (AA) MODIFICATIONS
draft of two aggregated igG antibodies generated by Biofidus AG
AGGREGATION ANALYSIS
draft of two igG antibodies one with a circled plus and one with a circled minus to symbolise charge heterogeneities generated by Biofidus AG
CHARGE HETEROGENITY
rectangularly ordered black circles with a few filled and empty ones
BIOACTIVITY STUDIES
twirled black line
HIGHER ORDER STRUCTURE CHARACTERIZATION
draft of igG Antibody with glycosylation pattern at the FC region generated by Biofidus AG
GLYCOSYLATION ANALYSIS
draft of two test tubes connected via a tube to symbolise CE analysis generated by BIofidus
CE ANALYSIS
draft of test tubes in a rack generated by Biofidus AG
CELL BASED ASSAYS
draft of typical SPR binding curves in an xy diagram generated by Biofidus AG
SPR ANALYSIS

Tell us about your project

We‘ll advice you to define your assay needs

By sending the contact form you agree to our privacy policy.
*By submitting this form, you are consenting to receive emails from: Biofidus AG. You can revoke your consent at any time by using the unsubscribe link, found at the bottom of every email. Please see our privacy policy.

Technologies used

For all inquiries related to our serum or plasma assay portfolio reach out directly to our expert PD Dr. Johannes Greiner.

Phone: +49(0)521 89 739 064 Mail: Johannes.Greiner@Biofidus.de
WordPress Cookie Plugin von Real Cookie Banner